A strain of Tritrichomonas foetus that remained refractory to dimetridazole, despite four courses of successively higher levels of medication (strain 4711, McLoughlin, 1965), was recovered from a bull and established intravaginally in hamsters. Tolerance for the chemical remained undiminished after maintenance of the strain in hamsters for 27 months. Also in hamsters, T. foetus that had no prior exposure to dimetridazole became unresponsive to the drug following pretreatment with suboptimal levels. The strain recovered from the bull and those from the hamsters had a detectable crossresistance to metronidazole and to aminitrozole. A previous report (McLoughlin, 1965) mentioned an apparent dimetridazole-resistant strain of Tritrichomonas foetus (now designated strain 4711) that had been recovered from Bull 4711. This animal had received a 5-day course of treatment at 25 mg/kg body weight admixed with the feed, and 5-day courses of treatment at 25, 50, and 100 mg/ kg, respectively, administered by capsule. The infection persisted and remained refractory to subsequent single intravenous injections of 20 and 30 mg/kg. The present report is a summary of data on the comparative response in hamsters to dimetridazole and other chemicals (Fig. 1) by this strain and a normal one that had no prior exposure to dimetridazole. The results of attempts to experimentally develop drug-resistant strains of T. foetus in laboratory animals are also reported. MATERIALS AND METHODS Tritrichomonas foetus recovered from Bull 4711 were cultured in Diamond's medium (Diamond, 1957) and then established intravaginally in hamsters essentially as suggested by Rubin and Cordray (1958). Periodically tubes of the same medium were inoculated with vaginal secretions from these hamsters, and the resulting cultures used to infect additional animals. On 7 occasions in 27 months from the time the strain was originally isolated, groups of usually 5 to 10 infected hamsters were given 100 mg/kg of dimetridazole1 per os for 3 or 5 days. Concomitantly, similar regimens were used in control groups of hamsters infected with a normal strain of T. foetus. Vaginal secretions from principal and control animals were examined microscopically and Received for publication 12 December 1966. 1Dimetridazole and metronidazole were supplied through the courtesy of Rhodia, Inc., New York, N.Y. by cultural techniques at least twice, usually 3 and 7 days after treatment. Other groups of hamsters infected with a normal strain of T. foetus were given suboptimal levels of dimetridazole for varying periods and then examined for trichomonads. Hamsters that were still positive for T. foetuis were given 50 or 100 mg/kg of dimetridazole per os for 3 or 5 days. The protocol for this portion of the study is given in Table II. On one occasion, 19 hamsters with intravaginal infections of normal T. foetus were given metronidazole orally for 5 days at a dose rate of 25 mg/kg body weight. Those that remained infected were given 100 mg/kg for 5 days and subsequently examined for trichomonads. In cross-resistance trials, groups of hamsters infected with strain 4711 or with an experimentally induced dimetridazole-resistant strain (EI) were given metronidazole (100 mg/kg) or aminitrozole (100 or 200 mg/kg) daily for 5 days. In one instance, an initial regimen of 100 mg/kg aminitrozole was followed by a second 5-day course of treatment at the 200 mg/kg level. In each trial, control groups of hamsters infected with a normal strain of T. foetus received medication identical with that of the corresponding principals. All ham-